RESEARCH COLLABORATION

NeuroActiva™welcomes an opportunity to form collaboration and partnerships to extend beyond our current focus on neuroscience. These new R&D relationships underscore the breadth and value of our technology.

NeuroActiva plans to develop new treatments for a broad range of acute and chronic conditions associated with neurological diseases including the development of new neuroprotective and neurogenesis pharmaceuticals. Principal elements of the Company's research strategy include the following:

* Targeting large markets with unmet medical needs: NeuroActiva targets large pharmaceutical markets that are not adequately served by existing therapies. The Company focuses on neurological disorders because of the substantial unmet market needs and the brain's high level of vulnerability to stress agents.

* Focusing on our areas of technical expertise in developing novel neurogenesis in combination of advanced drug delivery system that can administer the optimal dose of potent drug to the targeted areas in the central nervous system.

* Retaining commercial rights to product candidates: The Company will seek to retain significant commercial rights to its product candidates by conducting clinical development activities at least through initial proof of efficacy in humans. For larger and more complex clinical trials, and for worldwide marketing and distribution, NeuroActiva, Inc. intends to seek strategic collaborations with large pharmaceutical companies.

* Protecting proprietary position with broad patent coverage: NeuroActiva has built a strong domestic and international patent position protecting its rich compound and intellectual property estate.

For further information on potential research collaboration, please contact us online at Contact Form. Thank you.